REVISED POLICY ON THE ACCEPTANCE FOR REVIEW OF REVISED APPLICATIONS SUBMITTED 
UNDER PAS-02-009, COHORT STUDIES IN CANCER EPIDEMIOLOGY 

Release Date:  September 23, 2002 (see revision, NOT-CA-03-030)

NOTICE:	NOT-CA-02-026

National Cancer Institute (NCI) 
 (http://www.nci.nih.gov/)

The Division of Cancer Control and Population Sciences (DCCPS -- 
http://dccps.nci.nih.gov/) of the National Cancer Institute (NCI) 
announces an additional receipt date for REVISED R01 grant applications 
originally submitted under PAS-02-009, Cohort Studies in Cancer 
Epidemiology (NIH Guide October 11, 2001).  Revisions to applications 
originally submitted on either February 21, 2002, or February 21, 2003, 
will be accepted November 1, 2003, in addition to the usual annual 
receipt date.

The Division of Cancer Control and Population Sciences (DCCPS) of the 
National Cancer Institute (NCI) announced an annual receipt date for 
R01 applications from investigators intending to initiate, 
competitively supplement, or competitively renew epidemiologic cohort 
studies of human cancers.  This notice clarifies and revises the policy 
described in PAS-02-009, and published in the NIH Guide for Grants and 
Contracts on October 11, 2001.  This revised policy allows applicants 
to submit REVISED applications for an interim receipt date of November 
1, 2003, IN ADDITION TO the previously published receipt date of 
February 21, 2003.  It does NOT allow applicants to submit NEW 
applications on November 1, 2003.  An applicant planning to submit a 
REVISED application originally submitted under PAS-02-009 may submit 
either February 21, 2003, or November 1, 2003, under the procedures and 
policies outlined in the original PAS and available at the following 
URL address:  http://grants.nih.gov/grants/guide/pa-files/PAS-02-009.html.  

Prospective applicants for the November 1, 2003, receipt date are 
strongly encouraged to submit, by October 1, 2003, a Letter of Intent 
that includes the GRANT NUMBER, the name, address, and telephone number 
of the Principal Investigator, the identities of other key personnel 
and participating institutions, and that the revision is being 
submitted in response to PAS-02-009, Cohort Studies in Cancer 
Epidemiology.  Although a Letter of Intent is not required, is not 
binding, and does not enter into the review of a subsequent revised 
application, the information that it contains allow NIH staff to 
estimate the potential review workload and plan for the review.  

INQUIRIES

For further information, contact:

Sandra L. Melnick, Dr.P.H.
Chief, Analytic Epidemiology Research Branch
Epidemiology and Genetics Research Program
Division of Cancer Control and Population Sciences
National Cancer Institute
Executive Plaza North, Room 5100, MSC 7374
Bethesda, MD 20892-7324
Telephone:	(301) 435-4914
Fax:		(301) 402-4279
Email:		[email protected]

Weekly TOC for this Announcement
NIH Funding Opportunities and Notices

			Department of Health and Human Services (HHS)
NIH... Turning Discovery Into Health®